Integrated Wealth Concepts LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 12.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 33,206 shares of the healthcare conglomerate’s stock after purchasing an additional 3,608 shares during the period. Integrated Wealth Concepts LLC’s holdings in UnitedHealth Group were worth $13,801,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. California State Teachers Retirement System lifted its position in shares of UnitedHealth Group by 41,749.2% during the 2nd quarter. California State Teachers Retirement System now owns 567,446,754 shares of the healthcare conglomerate’s stock worth $235,847,894,000 after purchasing an additional 566,090,823 shares during the last quarter. Norges Bank bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $4,376,167,000. Corient Private Wealth LP bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $245,516,000. Legal & General Group Plc bought a new position in UnitedHealth Group in the second quarter worth $2,444,928,000. Finally, Jupiter Topco LLC acquired a new stake in UnitedHealth Group during the second quarter worth $2,019,844,000. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Stock Performance
UNH opened at $393.11 on Thursday. The company has a market capitalization of $352.85 billion, a price-to-earnings ratio of 25.30, a P/E/G ratio of 1.51 and a beta of 0.61. The business’s 50-day moving average price is $410.24 and its two-hundred day moving average price is $366.95. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is currently 59.72%.
More UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: UnitedHealth is investing nearly $1.5 billion in artificial intelligence to expand Optum Insight’s software capabilities, improve operating efficiency and create new growth opportunities. Can UnitedHealth’s AI Strategy Strengthen Optum Insight’s Growth?
- Positive Sentiment: Jim Cramer characterized UnitedHealth’s latest quarter as very strong and argued that the company continues to have profitable growth and a strong competitive position. Analysts tracked by Quiver Quantitative also have a median price target of $434.50, above the recent trading level. Jim Cramer Discusses UnitedHealth’s Profitable Growth
- Neutral Sentiment: UnitedHealth’s partial sale of its Florida WellMed primary-care clinic network to TPG brings in strategic capital while allowing UNH to retain an equity interest. Management was also expected to reaffirm its full-year earnings guidance, but investors are looking for evidence that the Optum turnaround is sustainable. UnitedHealth Sells WellMed to TPG
- Negative Sentiment: The TPG transaction raised concerns because the Florida WellMed operations have been associated with Optum Health’s recent profit problems. Investors questioned whether the deal signals a weaker outlook for the assets or reflects a need for outside capital during the turnaround. UnitedHealth Slips as TPG Buys Into Florida WellMed Clinics
- Negative Sentiment: Comments from CVS Health about continued high medical-cost growth pressured managed-care stocks, including UNH. UnitedHealth also continues to face commercial-insurance margin pressure, while parts of the Optum recovery remain incomplete. CVS Still Sees High-Trend Cost Growth
- Negative Sentiment: UnitedHealth trades at a substantial valuation premium to some managed-care peers despite having slower revenue growth, increasing sensitivity to disappointing guidance or execution. Broader healthcare-sector weakness added to the selling pressure. Why Is UNH Stock Trading at a Premium?
Analyst Ratings Changes
Several equities analysts recently commented on the company. Robert W. Baird upgraded UnitedHealth Group from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $287.00 to $453.00 in a research report on Thursday, July 16th. Wall Street Zen raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Bank of America reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 20th. BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $456.56.
Read Our Latest Research Report on UNH
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.19% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.
UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
